FDA Clearance Tracker · P070014
LIFESTENT FLEXSTAR & FLEXSTAR XL VASCULAR STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 13, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Feb 13, 2009
Approved
Time to decision
630 days
Received May 25, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P070014
- Device name
- LIFESTENT FLEXSTAR & FLEXSTAR XL VASCULAR STENT SYSTEM
- Applicant
- Bard Peripheral Vascular, Inc.
- Applicant location
- Tempe, AZ
- Received
- May 25, 2007
- Decided
- Feb 13, 2009
- Decision
- Approved
- Supplements
- 66 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE LIFESTENT FLEXSTAR AND FLEXSTAR XL VASCULAR STENT SYSTEM. THE DEVICE IS INDICATED FOR IMPROVEMENT OF LUMINAL DIAMETER IN THE TREATMENT OF SYMPTOMATIC DE-NOVO OR RESTENOTIC LESIONS UP TO 160 MM IN LENGTH IN THE NATIVE SUPERFICIAL FEMORAL ARTERY (SFA) AND PROXIMAL POPLITEAL ARTERY WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4.00 - 6.5 MM.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIP. The earliest in FDA's data is P000033, decided Apr 3, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Bard Peripheral Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.